These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21705892)

  • 1. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units.
    Ong DS; Jongerden IP; Buiting AG; Leverstein-van Hall MA; Speelberg B; Kesecioglu J; Bonten MJ
    Crit Care Med; 2011 Nov; 39(11):2458-63. PubMed ID: 21705892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-Induced Within-Host Resistance Development of Gram-Negative Bacteria in Patients Receiving Selective Decontamination or Standard Care.
    Noteboom Y; Ong DS; Oostdijk EA; Schultz MJ; de Jonge E; Purmer I; Bergmans D; Fijen JW; Kesecioglu J; Bonten MJ
    Crit Care Med; 2015 Dec; 43(12):2582-8. PubMed ID: 26448616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ; Tirado Balaguer MD; García Zúñiga ED; Granados Ortega J; Campos Aznar A; Moreno Muñoz R
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.
    Paramythiotou E; Lucet JC; Timsit JF; Vanjak D; Paugam-Burtz C; Trouillet JL; Belloc S; Kassis N; Karabinis A; Andremont A
    Clin Infect Dis; 2004 Mar; 38(5):670-7. PubMed ID: 14986251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
    Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
    Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
    Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
    Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
    Messadi AA; Lamia T; Kamel B; Salima O; Monia M; Saida BR
    Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.